SCHEMBL21319065

SCHEMBL21319065

CCCSc1nc(Cl)c(NC)c(N(C=O)Cc2ccc(C)cc2)n1

nearest known ligand 0.39

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ NPSR1 Q6W5P4 3/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ ADORA3 P0DMS8 1/20 0.32
▸ ALDH1A1 P00352 5/20 0.32
▸ LMNA P02545 2/20 0.32
▸ TSHR P16473 2/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ GAA P10253 2/20 0.32
▸ HTT P42858 2/20 0.31
▸ HSD17B10 Q99714 1/20 0.31
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ TLR7 Q9NYK1 1/20 0.31
▸ MAPT P10636 1/20 0.31
▸ HPGD P15428 1/20 0.31
▸ THRB P10828 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21318942 0.91 KMT2A (0.34) MEN1KMT2ANPSR1ADORA3ALDH1A1
SCHEMBL21318981 0.88 TOP2A (0.33) ADORA3GAAMAPTTHRB
SCHEMBL19945779 0.87 MEN1 (0.36) MEN1KMT2ANPSR1KDM4EALDH1A1
SCHEMBL21318973 0.85 — —
SCHEMBL21319054 0.85 ADORA3 (0.43) KMT2AKDM4EADORA3TLR7
SCHEMBL21318947 0.81 USP28 (0.39) ADORA3ALDH1A1LMNASMN1; SMN2GAA
SCHEMBL21318984 0.78 KMT2A (0.34) MEN1KMT2ANPSR1ADORA3ALDH1A1
SCHEMBL21318963 0.78 TSHR (0.31) TSHRL3MBTL1
SCHEMBL19945665 0.77 ABCB1 (0.38) KMT2AADORA3ALDH1A1SMN1; SMN2GAA
SCHEMBL21318986 0.76 ADORA3 (0.31) MEN1KMT2AKDM4EADORA3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3294740-B1 NOVEL SULFONIMIDOYLPURINONE COMPOUNDS AND DERIVATIVES FOR THE TREATMENT AND PROPHYLAXIS OF VIRUS INFECTION HOFFMANN LA ROCHE (CH) 2019-09-04 — — EP disclosed
Send feedback